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| INTRODUCTION
Globally, one of the major causal agents of hepatitis is the Hepatitis B virus (HBV). It is estimated that approximately 240 million people worldwide have chronic hepatitis B infection.
1 HBV infection can lead to liver cirrhosis, hepatic failure or hepatocellular carcinoma (HCC), which account for approximately 780,000 deaths each year globally.
2
HCC is the fifth most common cancer and the third leading cause of cancer-related mortality in the world, 3 and it is estimated that approximately 53% of cases with HCC in the world are related to HBV. which are typically 20-22 nucleotides in length. 5 They modulate an extensive array of biological processes, such as inflammatory responses, cell differentiation, proliferation and apoptosis. 6 Although the mode of action of miRNAs is not fully understood, there is evidence that they act post-transcriptionally as negative regulators of gene expression through binding to target mRNAs regions, which results in mRNA cleavage or translational repression. 7 There is increasing evidence that miRNAs regulate the expression of oncogenes and tumour suppressor genes, and consequently, their deregulation would have a crucial role in the instigation, progression and prognosis of various types of cancer.
8-10
It has been proposed that single nucleotide polymorphisms (SNPs) found in miRNA genes affect miRNA transcription, processing and interactions with target mRNAs. 11 Several studies have investigated SNPs in miRNA genes for evidence of association with HBV infection and the development of HCC. (Zhou et al.
12
) performed a metaanalysis and found that miR-196a2 rs11614913 was associated with susceptibility to HBV infection, 12 whereas no evidence of association was found between miR-146a rs2910164, miR-499 rs3746444, and miR-149 rs2292832 with hepatitis B risk. However, a different study found that miR-149 rs2292832 was associated with HBV-related HCC. 13, 14 In addition, Su et al., (2015) 15 recently identified an association between miR-146a rs2910164 and the development of HCC in an Asian population. The lack of consistent findings supporting a role of miRNA SNPs in HBV infection and related complications may be because of several factors including genetic variations in the populations or ethnic groups studied and the number of samples (eg, cohort size) tested in these different studies.
In this study, we investigated ten SNPs in different miRNA genes (miR-499 rs3746444, miR-423 rs6505162, miR-26a1 rs7372209, miR-608 rs4919510, miR-604 rs2368392, miR-492 rs2289030, miR-149 rs2292832, miR-146a rs2910164, miR-196a2 rs11614913
and miR-30a rs1358379) for evidence of a role in the susceptibility, clearance and persistence of HBV infection within a Saudi Arabian population. This study identified evidence of association between several miRNA SNPs and HBV infection, prognosis and related liver complications.
| MATERIALS AND METHODS

| Subjects
A total of 1352 HBV-infected Saudi Arabian patients were recruited for this study. These patients were identified and subgrouped as follows: 585 were inactive asymptomatic HBV carriers, 222 were active symptomatic HBV carriers, 145 were HBV-infected patients diagnosed with liver cirrhosis or cirrhosis+HCC and 400 were HBVcleared subjects. Furthermore, a group of 600 randomly selected, and had normal to near-normal liver enzymes were considered to have a nonreplicative HBV infection and were grouped as inactive asymptomatic HBV carriers. 16 Subjects, who were found to have repeated detection of HBsAg, were negative for HbeAg, and positive for antibodies to HBeAg (anti-HBe) with elevated serum ALT levels were grouped as active HBV carriers. Individuals from either of these groups showed no evidence of cirrhosis. Liver cirrhosis among patients with HBV infection was confirmed by liver biopsy. Diagnosis of HCC was performed using computed tomography and/or magnetic resonance imaging of liver according to guidelines published for the diagnosis and management of HCC. 17 Control subjects were characterized by pathophysiology of HBV infection and related liver complications. However, differences in the association of examined SNPs with various clinical stages indicate variations in the respective functional roles of these polymorphisms and their miRNAs, and thus, further investigation to fully explore their therapeutic potential is warranted.
K E Y W O R D S
carcinoma, hepatitis B, hepatocellular, microRNA, polymorphism the absence of any known serological markers for HBV and by the lack of any evidence of liver disease.
| Genotyping miRNA single nucleotide polymorphisms
Genomic DNA from peripheral blood mononuclear cells was extracted using Gentra Puregene kit according to the manufacturer's protocol (Qiagen, Hilden, Germany). Blood samples from patients and controls
were genotyped for the miRNA SNPs using either a PCR-based genotyping assay or the TaqMan assay.
| PCR-based genotyping assay
Specific primers (forward 5ʹ-AGAGTGAGGGAAAGGCACAA -3ʹ; reverse 5ʹ-GGGGTGAAAGAGAAGCGTAA-3ʹ) for mir-499 rs3746444
were designed using Primer3 v.0.4.0 (http://frodo.wi.mit.edu/ primer3). All PCR reactions were performed using the Veriti 96-Well Thermal Cycler (Applied Biosystems, Foster City, CA, USA). Amplified PCR products were separated on 2% agarose gels, using electrophoresis and visualized using ethidium bromide staining (0.5 μg/mL).
DNA fragments were analysed by direct sequencing using a BigDye 
| TaqMan genotyping assay
Nine miRNA SNPs-rs6505162, rs7372209, rs4919510, rs2368392, rs2289030, rs2292832, rs2910164, rs11614913 and rs1358379
were genotyped using the TaqMan allelic discrimination assay with a 7900 HT Fast Real Time PCR System (Applied Biosystems).
TaqMan amplifying primers and probes were ordered from Applied Biosystems. For each SNP, one of the allelic probes was labelled with FAM and the other was labelled with VIC. PCR was performed using a TaqMan universal master mix (Applied Biosystems) at a probe concentration of 20×. Reactions were performed in a 96-well plate using 20 ng of genomic DNA in a total reaction volume of 25 μL.
PCR cycling conditions were as follows: plates were first heated at 50°C for 2 minutes and then at 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1.5 minutes. The fluorescence intensity of each well in the TaqMan assay plate was read.
Fluorescence data files from each plate were analysed using automated software (SDS 2.4).
| Statistical analyses
Statistical analyses were performed using SPSS version 20 (SPSS Inc., Chicago, IL, USA). The genotype and allele distributions for each miRNA SNP in the patient groups, controls and clearance group were assessed using Pearson's χ² test. Evidence of an association between
SNPs and disease status was tested under additive, dominant and recessive genetic models, and results were expressed in terms of the odds ratio (OR) and 95% confidence interval (CI). A P value ≤.05 was considered statistically significant. To detect associations among categorical variables, we used chi-square statistics and one-way ANOVA to compare the means of continuous data. All miRNA genes investigated in this study were used as input core data for Genomatix
Pathway Analysis (Genomatix, Munich, Germany).
| RESULTS
| General characteristics of the subjects
A total of 1352 HBV-infected patients and 600 healthy uninfected controls were analysed in this study. Baseline characteristics of the subjects are summarized in Table S1 . The cases in this study included 585 inactive HBV carriers, 222 active HBV carriers, 145 HBV-infected patients with cirrhosis+HCC and 400 HBV-cleared individuals. All subjects were Saudi Arabian nationals.
| Genotyping
In the present analysis, 10 SNPs in different microRNA genes were investigated for evidence of an association with HBV infection and its related complications. These SNPs were miR-499 rs3746444, miR-423 rs6505162, miR-26a1 rs7372209, miR-608 rs4919510, miR-604 rs2368392, miR-492 rs2289030, miR-149 rs2292832, miR146a rs2910164, miR-196a2 rs11614913 and miR-30a rs1358379.
Genotype frequency distributions of all SNPs analysed in this study were in Hardy-Weinberg Equilibrium (data not shown).
Single nucleotide polymorphisms genotype distributions in controls and HBV-infected patients (excluding the HBV-cleared group) are shown in Table S2 were associated with susceptibility to HBV infection under a dominant mode with an OR of 0.597 and 0.780, respectively (Table S2) .
Next, these 10 polymorphisms were examined to determine whether they were associated with HBV clearance. (Table S3) .
We also examined the potential role of these miRNA SNPs in the progression of HBV infection to more severe stages of liver disease.
Six SNPs showed a significant association with development of cirrhosis or cirrhosis+HCC among HBV-infected patients compared to that found in active HBV carriers ( 
| DISCUSSION
In this study, 10 SNPs in different miRNAs were analysed to determine whether there was evidence of an association with HBV susceptibility, the progression of HBV-related liver diseases or viral clearance in recovered individuals. Several previous studies investigated miR-30a rs1358379 for association with different carcinomas. [18] [19] [20] However,
there is a lack of data to correlate rs1358379 alleles or genotypes with susceptibility to HBV infection and the risk of related liver diseases.
In the present study, we found support of an association between the rs1358379 C allele with susceptibility to HBV infection. It was also determined that the T allele of this SNP is associated with an increased ability of HBV-infected patients to clear the virus. In addition, miR-30a rs1358379 was the only polymorphism tested in this study that was associated with HBV persistence. Upon further analysis to determine the effect of miR-30a rs1358379 on disease severity, we found that the rs1358379 C allele was associated with an increased risk of developing cirrhosis and HCC compared to that found in active HBV carriers. Budhu et al. 21 investigated the role of miRNAs in metastatic HCC and found that miR-30a was downregulated, and consequently, its targets were upregulated. In this context, we propose that rs1358379 modulates the expression of mature miR-30a that results in changes in target genes, which are involved in HCC development.
The SNPs miR-149 rs2292832 22 and miR-196a2 rs11614913 23 have been widely tested to determine their possible roles in various types of cancer. We found that rs2292832 was associated with an increased risk of HBV infection and progression to cirrhosis and HCC. Our findings are consistent with those of previous studies that found an association of miR-149 C > T with HBV-related HCC. 13, 14 We T A B L E 1 Genotypic and allelic distribution of miRNA single nucleotide polymorphisms (SNPs) when the clearance group was compared with hepatitis B virus-infected patients demonstrated that high levels of miR-196a-2 exerted an oncogenic potential promoting cancer cell migration and invasion.
The rs2910164 polymorphism, which is located in the miR-146a
gene, is associated with several types of cancer. 7 We found that the rs2910164 G-allele was associated with an increased risk of HBV T A B L E 1 (Continued) infection. In contrast, a recent meta-analysis did not find any significant correlation between the miR-146a rs2910164 G > C polymorphism and hepatitis B susceptibility. 12 This disparity may be because of the comparatively small sample sizes tested in the studies examined in this meta-analysis. In the present study, we found that the risk C allele under a dominant model was associated with HBV clearance. 
MiR-26a1 rs7372209 is an understudied polymorphism in HBV infection and its complications. We found that the rs7372209 T allele under a dominant model was specifically associated with progression to cirrhosis+HCC in HBV-infected patients. Previous studies have reported that mir-26a1 inhibits cancer cell proliferation via proposed mechanisms including induction of cell cycle arrest in HCC cells.
34
However, the functional significance and role of this SNP on miR-26a1 expression is not known. Stenholm et al. 35 evaluated the effects of miRNA polymorphisms on prognosis of advanced gastric cancer and proposed that the T allele of rs7372209 was associated with impaired mir-26a1 expression or function. This proposal is consistent with our results in that we posit low expression of miR-26a1 has a subsequent effect on regulation of cell immunity.
A previous study found that rs4919510 in the miR-608 gene affects the secondary structure and ancestral miR-608 stem-loop sequence, thereby modulating the ability of the microRNA to bind to potential targets. 36 In the present study, we found evidence of an association with the development of cirrhosis and HCC in HBV-infected patients.
The rs4919510 G-allele under all three genetic models (additive, dominant and recessive) was associated with an increased risk of liver cirrhosis and HCC. Several studies have linked miR-608 rs4919510
with different cancers such as nasopharyngeal carcinoma, 37 colorectal cancer 38 and breast cancer. 39 Although we speculate that a comparable mechanism underlies the role of the rs4919510 G-allele and increased risk of HCC, further experimental evidence is required.
In this study, enrichment analysis of these 10 microRNA genes generated two functional pathways, HBV and HCC. The presence of these genes in these functional pathways supports their association with HBV and HCC. Disease pathway analysis predicted that mir-146a, mir-26a1, mir-30a, mir196a2, mir499a and mir-149 are involved in HBV infection (Figure 1 ), a prediction confirmed by our findings. Similarly, mir-30a, mir-146a, mir499a, mir-26a1, mir196a2, mir423 and mir-604 are involved in the disease pathway for HCC (Fig.   S1 ). These microRNAs may have direct or indirect effects on several regulatory molecules that directly bind to DNA sequences in the nucleus. However, further experiments are required to elucidate the exact role of these genes in the pathogenesis of HBV infection and its complications. 
